Cargando…

The importance of improving health literacy to lower cardiovascular risk in type 2 diabetes

Detalles Bibliográficos
Autores principales:	Hansen, Dominique, Belkhouribchia, Jamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978198/ https://www.ncbi.nlm.nih.gov/pubmed/31993577 http://dx.doi.org/10.1016/j.eclinm.2019.11.016

Ejemplares similares

Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post‐hoc analysis
por: Aso, Yoshimasa
Publicado: (2021)

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018)

Tackling Cardiovascular Risk in Type 2 Diabetes: Does Baseline Glucose Control Matter?
por: Nicholls, Stephen J., et al.
Publicado: (2018)

Fetal exposure to parental smoking and the risk of type 2 diabetes: Are lifestyle‐related factors more important?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2015)

The Need for Trauma-Sensitive Language Use in Literacy and Health Literacy Screening Instruments
por: Lincoln, Alisa K., et al.
Publicado: (2013)

Recommendations for Advancing Health Literacy Measurement
por: McCormack, Lauren, et al.
Publicado: (2013)

Health Literacy: Read All about It …
por: Horgan, Denis, et al.
Publicado: (2017)

Involving Children in Health Literacy Research
por: Jenkins, Catherine L., et al.
Publicado: (2022)

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
por: Schernthaner, Guntram, et al.
Publicado: (2018)

Health Literacy: The Common Denominator of Healthcare Progress
por: Pitts, Peter J., et al.
Publicado: (2021)

The call for a strategic framework to improve cancer literacy in Europe
por: Sørensen, Kristine, et al.
Publicado: (2020)

Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes
por: Kim, Hae Jin, et al.
Publicado: (2017)

Public health literacy unsold during panic buying
por: Shoib, Sheikh, et al.
Publicado: (2022)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Kidney health for all: bridging the gap in kidney health education and literacy
por: Langham, Robyn G., et al.
Publicado: (2022)

A Health Equity Implementation Approach to Child Health Literacy Interventions
por: Naccarella, Lucio, et al.
Publicado: (2022)

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
por: Schernthaner, Guntram, et al.
Publicado: (2020)

Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
por: Fareed, Areeba, et al.
Publicado: (2023)

Effects of medical therapies on retinopathy progression in type 2 diabetes: Is blood pressure control the lower the better?
por: Chang, Chia‐Hsiun, et al.
Publicado: (2011)

Improving Prediction of Risk for the Development of Type 1 Diabetes—Insights From Populations at High Risk
por: Wherrett, Diane K.
Publicado: (2021)

Is Endogenous GLP-1 the Only Important Enhancer of Glucose-Induced Insulin Secretion in Type 2 Diabetes?
por: Deacon, Carolyn F.
Publicado: (2012)

Artificially intelligent proteomics improves cardiovascular risk assessment
por: Sze, Siu Kwan
Publicado: (2019)

The Benefits and Risks of New Therapies for Type 2 Diabetes
por: Asche, Car V., et al.
Publicado: (2008)

Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
por: Shehadeh, Naim, et al.
Publicado: (2018)

Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
por: McGuire, Darren K., et al.
Publicado: (2021)

Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
por: Lin, Chun‐Hsien, et al.
Publicado: (2020)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Public Health Genomics Approach to Type 2 Diabetes
por: Khoury, Muin J., et al.
Publicado: (2008)

Health literacy of ethnic minority in remote China: precise intervention is needed
por: Hu, Huaqin, et al.
Publicado: (2021)

Important steps to improve translation from medical research to health policy
por: Jiang, Fan, et al.
Publicado: (2013)

Important Systemic Factors for Improving Adolescent Mental Health Literacy
por: Shahraki-Mohammadi, Azita, et al.
Publicado: (2023)

Does Krüppel Like Factor 15 Play an Important Role in the Left Ventricular Hypertrophy of Patients with Type 2 Diabetes?
por: Zhao, Yuguang, et al.
Publicado: (2017)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2020)

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
por: Bourazana, Angeliki, et al.
Publicado: (2022)

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2017)

Rethinking Adherence: A Health Literacy–Informed Model of Medication Self-Management
por: Bailey, Stacy C., et al.
Publicado: (2013)

The Emergence of Environmental Health Literacy—From Its Roots to Its Future Potential
por: Finn, Symma, et al.
Publicado: (2015)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
por: Lorber, Daniel
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d54482r7fpqavn8a2vnon6g5cd